Literature DB >> 20645787

Tanshinone IIA protects rat primary hepatocytes against carbon tetrachloride toxicity via inhibiting mitochondria permeability transition.

Bin Zhu1, Qing Zhai, Bo Yu.   

Abstract

Tanshinone IIA (Tan IIA), one of the key components of Salvia milthorrhiza Bunge (Lamiaceae), is used to treat liver disease. The present study was carried out to investigate the possible mechanisms involved in the hepatoprotective effects of Tan IIA on carbon tetrachloride (CCl(4))-induced hepatocyte toxicity. In cultures treated with 1 or 2 microM CCl(4), Tan IIA (10-75 microM) significantly increased hepatocyte survival rates. However, only at a concentration of 75 microM could Tan IIA partially reverse the CCl(4) (3 microM)-induced decrease of survival rate (34 +/- 3% vs. 18 +/- 3%, n = 8, p < 0.01). In isolated mitochondria energized with succinate, Tan IIA could inhibit the large swelling effect induced by CCl(4) (1 and 2 microM). Base on these results, Tan IIA could protect rat primary cultured hepatocytes from CCl(4)-induced toxicity partially by the inhibitory effect on the opening of mitochondrial permeability transition (MPT).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645787     DOI: 10.3109/13880200903179699

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  7 in total

1.  Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells.

Authors:  Zhi-Kai Dai; Jiang-Ke Qin; Jiao-E Huang; Yong Luo; Qing Xu; Hai-Lu Zhao
Journal:  J Nat Med       Date:  2011-08-19       Impact factor: 2.343

2.  Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.

Authors:  Asmaa A Ashour; Amal H El-Kamel; Doaa A Abdelmonsif; Hoda M Khalifa; Alyaa A Ramadan
Journal:  Int J Nanomedicine       Date:  2021-12-08

Review 3.  Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells.

Authors:  Florent Duval; Jorge E Moreno-Cuevas; Maria Teresa González-Garza; Carlos Rodríguez-Montalvo; Delia Elva Cruz-Vega
Journal:  Adv Pharmacol Sci       Date:  2014-11-20

4.  Tanshinone IIA pretreatment protects free flaps against hypoxic injury by upregulating stem cell-related biomarkers in epithelial skin cells.

Authors:  Zihan Xu; Lijun Wu; Yaowen Sun; Yadong Guo; Gaoping Qin; Shengzhi Mu; Ronghui Fan; Benfeng Wang; Wenjie Gao; Zhenxin Zhang
Journal:  BMC Complement Altern Med       Date:  2014-09-04       Impact factor: 3.659

5.  Tanshinone IIA attenuates renal injury during hypothermic preservation via the MEK/ERK1/2/GSK-3β pathway.

Authors:  Linhao Xu; Yizhou Xu; Zhoujing Zhu; Huiquan Gu; Chaofeng Chen; Jian Chen
Journal:  BMC Complement Med Ther       Date:  2021-10-08

6.  Protective effect of tanshinone IIA against radiation-induced ototoxicity in HEI-OC1 cells.

Authors:  Shasha DU; Qiwei Yao; Peixin Tan; Guozhu Xie; Chen Ren; Quanquan Sun; Xiao Zhang; Rong Zheng; Kaijun Yang; Yawei Yuan; Quan Yuan
Journal:  Oncol Lett       Date:  2013-07-24       Impact factor: 2.967

7.  Tanshinone IIA pretreatment renders free flaps against hypoxic injury through activating Wnt signaling and upregulating stem cell-related biomarkers.

Authors:  Zihan Xu; Zhenxin Zhang; Lijun Wu; Yaowen Sun; Yadong Guo; Gaoping Qin; Shengzhi Mu; Ronghui Fan; Benfeng Wang; Wenjie Gao
Journal:  Int J Mol Sci       Date:  2014-10-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.